AIM ImmunoTech Cash from Discontinued Operations Adjustment (Quarterly) Insights

AIM ImmunoTech, Inc. (AIM)

1.34 0.00 (0.00%) USD | NYAM | Jan 16, 16:00

1.33 -0.01 (-0.75%) After-Hours: 20:00

View Cash from Discontinued Operations Adjustment (Quarterly) for AIM.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Cash from Discontinued Operations Adjustment (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Cash from Discontinued Operations Adjustment (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Cash from Discontinued Operations Adjustment (Quarterly) Benchmarks

Start Trial

Halozyme Therapeutics, Inc.	--
Perspective Therapeutics, Inc.	--
Protalix Biotherapeutics, Inc.	--
Electromed, Inc.	--
Armata Pharmaceuticals, Inc.	--